How to Host TweetChats That Deliver Value to Pharma and Its Stakeholders Tips from Boehringer IngelheimPharmaguy interviews Patricia Alves, Social Media Community Manager, and Jaclyn Fonteyne, Social Media Specialist, (see Bios), at Boehringer Ingelheim, about their experience with tweetChats to inform stakeholders, build trust, and drive innovation in healthcare.
Aired LIVE on: Thursday, 12 June 2014
Check Out Business Podcasts at Blog Talk Radio with Pharmaguy on BlogTalkRadio
Visit this Pharma Marketing Talk Segment Page and listen to the live show or the archived audio podcast afterward. This show and ALL Pharma Marketing Talk shows are available as podcasts via PMT on iTunes (FREE!).
In 2013, Boehringer Ingelheim took its first steps into the world of TweetChats, running these ‘online Twitter conferences’ in a number of disease areas, including atrial fibrillation, chronic obstructive pulmonary disorder (COPD) and lung cancer. Despite the regulatory challenges posed by such activities, these were all successful, both in terms of delivering value on all sides and for staying compliant.
“Tweetchats have gained increasing publicity within healthcare recently as a number of pharmaceutical companies, including Boehringer Ingelheim, have taken their first steps into this new form of social media engagement. As more companies explore this activity, we felt it was important to share some of the lessons we have learned around why and how pharmaceutical companies should run Tweetchats.” — from whitepaper: “How pharma Tweetchats can drive healthcare innovation” (see embedded version below).
Questions/Topics of Discussion
- What is a Tweetchat is and why are they important for pharma?
- What are the essential steps to planning a successful Tweetchat?
- What are measures of success?
- Give us you views on the future of Tweetchats within the broader pharma and healthcare space.
Patricia Alves joined Boehringer Ingelheim in 2012 and has been working in Social Media since January 2013 as a Social Media Community Manager in the Global Media and PR Team. Patricia Alves was born and raised in Madeira Island in Portugal and completed her Masters in Communications in 2010 in the Universidade Católica Portuguesa.
Her first experience with Social Media from a business perspective was during her 9 Month training at Microsoft Portugal, working as an Audience Marketing Trainee – where she was responsible for the companies regional blog and social media activities.
Patricia, alongside with Jaclyn Fonteyne, shares responsibilities in the development of the strategy, planning and implementations of Boehringer Ingelheim’ s social media external facing activities across the global organization. She is also responsible for the development of the internal social media guidelines and has the opportunity to work very closely not only to the PR Brand Teams but also with Medical, Marketing and Legal counterparts throughout the company.
Jaclyn Fonteyne has been with Boehringer Ingelheim GmbH as a Social Media Specialist since July 2013. She studied International Affairs and Psychology at Lafayette College in Pennsylvania, but got her first taste of Healthcare Social Media through an internship with the Boehringer Ingelheim Corporate Media & PR team in 2011 focusing on Boehringer’s growing Social Media Presence. She continued her interest in Healthcare Marketing & Communications with agency experience specializing in Digital and Social Media Strategy within Healthcare.
Working in the Boehringer Corporate Social Media Team, Jaclyn, alongside Patricia Alves, is responsible for maintaining and monitoring all external facing Social Media Channels, the content that populates them, and the strategy and innovation each one. She has the opportunity to work very closely not only with internal Brand Teams consisting of PR, Marketing, Medical and Legal colleagues, but also gets to interact with influencers and experts within the Healthcare Social Media sphere.